Dr. Herati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
430 E 29th St
5th Floor Room 512
New York, NY 10016
Education & Training
University of Pennsylvania Health SystemFellowship, Infectious Disease, 2011 - 2013
Johns Hopkins UniversityResidency, Internal Medicine, 2008 - 2011
Washington University in St. Louis School of MedicineClass of 2008
Certifications & Licensure
NY State Medical License 2019 - 2026
PA State Medical License 2011 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Flu Vaccine Responses in the Setting of Melanoma Treatment Start of enrollment: 2017 Oct 20
Publications & Presentations
PubMed
- 1767 citationsRadiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancerChristina Twyman-Saint Victor, Andrew J. Rech, Amit Maity, Ramesh Rengan, Kristen E. Pauken
Nature. 2015-04-16 - 450 citationsA single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanomaAlexander C. Huang, Robert J. Orlowski, Xiaowei Xu, Rosemarie Mick, Sangeeth M. George
Nature Medicine. 2019-02-25 - 211 citationsMethotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease.Rebecca H. Haberman, Ramin S. Herati, David Simon, Marie I. Samanovic, Rebecca B Blank
Annals of the Rheumatic Diseases. 2021-05-25
Journal Articles
- Research Paper Deep Immune Profiling by Mass Cytometry Links Human T and NK Cell Differentiation and Cytotoxic Molecule Expression PatternsRamin Herati, MD, ScienceDirect
- Research Paper Deep Immune Profiling by Mass Cytometry Links Human T and NK Cell Differentiation and Cytotoxic Molecule Expression PatternsRamin Sedaghat Herati, Kyong-Mi Chang, ScienceDirect
Press Mentions
- Patients Recovered from COVID-19 May Require Just One Dose of mRNA VaccineMarch 9th, 2021
- Patients Recovered from COVID-19 May Require Just One Dose of mRNA VaccineMarch 9th, 2021
Penn Team Tracks Rare T Cells in Blood to Better Understand Annual Flu VaccineFebruary 18th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
